AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 221 filers reported holding AMICUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,483,886 | -3.1% | 286,504 | +0.1% | 0.34% | -0.9% |
| Q2 2023 | $3,593,981 | +49.7% | 286,145 | +32.2% | 0.34% | +36.7% |
| Q1 2023 | $2,400,530 | -8.8% | 216,459 | +0.4% | 0.25% | -12.2% |
| Q4 2022 | $2,633,526 | +17.3% | 215,686 | +0.3% | 0.29% | +15.3% |
| Q3 2022 | $2,245,000 | +6.5% | 215,069 | +9.6% | 0.25% | +13.2% |
| Q2 2022 | $2,107,000 | +55.4% | 196,196 | +37.0% | 0.22% | +81.0% |
| Q1 2022 | $1,356,000 | -17.4% | 143,221 | +0.8% | 0.12% | -16.6% |
| Q4 2021 | $1,641,000 | +11.0% | 142,064 | -0.6% | 0.14% | +9.0% |
| Q3 2021 | $1,479,000 | +8.8% | 142,864 | +1.3% | 0.13% | -32.1% |
| Q2 2021 | $1,360,000 | -5.2% | 141,064 | -2.8% | 0.20% | +14.0% |
| Q1 2021 | $1,434,000 | -43.5% | 145,064 | +32.1% | 0.17% | -48.3% |
| Q4 2020 | $2,537,000 | – | 109,855 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |